Key facts
- Senate Democrats unveiled a roadmap of proposals to lower prescription drug costs.
- The plan aims to expand Medicare drug price negotiations by making more drugs subject to negotiation and allowing earlier negotiation.
- Democrats are considering incorporating international drug prices into Medicare negotiations.
- The proposals also address bolstering Medicare's price gouging penalties and lowering out-of-pocket costs, including potential caps for chronic care drugs.
Senate Democrats have released a blueprint of proposals aimed at lowering prescription drug costs, presenting it as a key policy focus ahead of the midterm elections. The plan, led by members of the Senate Finance Committee minority, seeks to counter the White House's approach and bolster the party's message on affordability.
Democrats argue that their efforts, such as those included in the Inflation Reduction Act, are responsible for forcing drug companies to negotiate prices with the federal government for Medicare. They contrast this with President Trump's voluntary pricing deals, which they criticize as secret and unserious.